Literature DB >> 12835323

Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis.

Hong Liu1, Rachelle E Toman, Sravan K Goparaju, Michael Maceyka, Victor E Nava, Heidi Sankala, Shawn G Payne, Meryem Bektas, Isao Ishii, Jerold Chun, Sheldon Milstien, Sarah Spiegel.   

Abstract

There are two isoforms of sphingosine kinase (SphK) that catalyze the formation of sphingosine 1-phosphate, a potent sphingolipid mediator. Whereas SphK1 stimulates growth and survival, here we show that SphK2 enhanced apoptosis in diverse cell types and also suppressed cellular proliferation. Apoptosis was preceded by cytochrome c release and activation of caspase-3. SphK2-induced apoptosis was independent of activation of sphingosine 1-phosphate receptors. Sequence analysis revealed that SphK2 contains a 9-amino acid motif similar to that present in BH3-only proteins, a pro-apoptotic subgroup of the Bcl-2 family. As with other BH3-only proteins, co-immunoprecipitation demonstrated that SphK2 interacted with Bcl-xL. Moreover, site-directed mutation of Leu-219, the conserved leucine residue present in all BH3 domains, markedly suppressed SphK2-induced apoptosis. Hence, the apoptotic effect of SphK2 might be because of its putative BH3 domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835323     DOI: 10.1074/jbc.M304455200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  139 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

2.  Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.

Authors:  Randy S Schrecengost; Staci N Keller; Matthew J Schiewer; Karen E Knudsen; Charles D Smith
Journal:  Mol Cancer Res       Date:  2015-08-13       Impact factor: 5.852

3.  A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection.

Authors:  Ludovic Gomez; Melanie Paillard; Megan Price; Qun Chen; Geoffrey Teixeira; Sarah Spiegel; Edward J Lesnefsky
Journal:  Basic Res Cardiol       Date:  2011-10-15       Impact factor: 17.165

4.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

6.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

Review 7.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

Review 8.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

9.  A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.

Authors:  Ashley J Snider; Toshihiko Kawamori; Sarah G Bradshaw; K Alexa Orr; Gary S Gilkeson; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2008-09-24       Impact factor: 5.191

10.  Sphingosine kinase 2 promotes lipotoxicity in pancreatic β-cells and the progression of diabetes.

Authors:  Ziyu Song; Wei Wang; Ning Li; Sishan Yan; Kuan Rong; Tian Lan; Pu Xia
Journal:  FASEB J       Date:  2018-11-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.